Vomiting is rare but occurs in approximately 5% of users during the first week, particularly at doses above 0.75mg on an empty stomach
Regulatory Guidelines for ADA Assessment The assessment of immunogenicity is a key part of the regulatory approval process for biologics
Your program begins with a comprehensive evaluation health history, current medications, and relevant bloodwork
Ngomba RT, Biagioni F, Casciato S et al (2005) The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy
Topics in Fluorescence Spectroscopy, vol 1
Murray-Thomas T, Cruz JM, Harder-Lauridsen NM, Olsen AH, Williams R, Major-Pedersen A